Company intelligence

LUCY

Innovative Eyewear, Inc. · NASDAQ · Healthcare

Price$0.87+0.70% · +$0.01

Market cap7.55MEquity value

P / E-0.7Trailing ratio

Volume160.2KLatest session

Market data

LUCY price chart

TradingView

Related signals

1 min delayed

Browse public LUCY signals with their source context and measured market impact. Open any signal for its permanent analysis page.

LUCYAug 24, 2026+53.52% since signal

Innovative Eyewear expands Lucyd Armor to 150+ stores, October sales set

Innovative Eyewear announced a test rollout of Lucyd Armor at more than 150 large-box stores, with sales expected to begin in October 2026. CEO Harrison Gross frames this expansion as a vote of confidence in Lucyd Armor and highlights hands-free AI features like translation. The move could meaningfully lift near-term revenue and improve channel visibility for LUCY.

View signal analysis

LUCYJul 8, 2026-26.46% since signal

Innovative Eyewear expands Canada rollout, eyes U.S. 50-store test for LUCY

Innovative Eyewear gains on Canada rollout and a U.S. retailer test, signaling growth potential for LUCY. The Canada launch taps a $4.5B optical market via the Visiguard program, with placements across FYidoctors and Visique in Canada and California; Q2 net sales were about $0.99M, up 71% YoY, and H1 2026 rose 71% to $1.77M, underscoring Lucyd Armor demand.

View signal analysis

Research